Fresenius Medical Care AG Stock-Based Compensation Growth & History (FME)

Fresenius Medical Care AG's stock-based compensation was €0 for fiscal 2021.

View full Fresenius Medical Care AG company overview

Fresenius Medical Care AG annual stock-based compensation history

Fresenius Medical Care AG annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20212021-12-31€0
20192019-12-31€2.0M−€8.8M−81.46%
20182018-12-31€10.7M−€36.1M−77.05%
20172017-12-31€46.8M€19.4M+70.64%
20162016-12-31€27.4M€19.1M+227.75%
20152015-12-31€8.4M

Fresenius Medical Care AG stock-based compensation trends

Over the last five fiscal years, Fresenius Medical Care AG's stock-based compensation decreased from €27.4M to €0, a change of −€27.4M. The latest reported quarter, Q2 2019 · Jun 30, shows €1.3M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Fresenius Medical Care AG source filings ↗

Community posts

It’s quiet here.

No posts about FME yet. Start the conversation.

Write the first post